The problem: Preventable Medication-Related Problems
The TRHC solution: Clinical Intelligence and Personalized Medication Management for Pharmacy
Health plans need a way to understand which members are at highest risk of costly medication-related problems, like adverse drug events (ADE), falls and hospitalization. Partner with Tabula Rasa HealthCare (TRHC) to identify medication-related risks and then intervene with high-risk members so you can improve adherence and therapeutic outcomes and reduce unnecessary medical and pharmacy expenditures.
Tabula Rasa HealthCare is disrupting the fields of medication adherence and safety. For more than thirty years, traditional medication software systems have offered clinicians a binary view of drug-to-drug interactions, presenting an assessment of one single drug against one single drug. These legacy systems are (arguably*) adequate to assess the safety of a medication regimen consisting of only one or two medication. However, for the elderly and chronically ill, a medication profile of just a few drugs often leaves these patients at high risk of an ADE. The average Medicare patient typically takes 10 different medications a day, and current technologies are inadequate to optimize safety and minimize risk.
What we do for health plans:
TRHC leverages technology to improve health care and reduce costs. TRHC’s Medication Risk Mitigation (MRM) technology delivers a simultaneous, multi-drug review which identifies medication-related risks across a variety of pharmacokinetic and pharmacodynamic safety factors and presents meaningful opportunities to mitigate those risks. TRHC partners with health plans and provider groups in comprehensive medication therapy management (MTM) and transitions of care (TOC) programs to identify and substantially mitigate the risk associated with ADEs.
The TRHC model (shown right) includes medication risk stratification, assessment – which includes medication risk scoring, clinical interventions, and ongoing support. TRHC uses real-time pharmacy claims data to identify medication-related risks, utilizing pharmacodynamic and pharmacokinetic principles to determine risk and probability of an ADE.
Our newest company, SinfoniaRx, offers a comprehensive approach to patient and population health. Their team of adherence-founded pharmacists solely focus on medication reviews and clinical interventions to improve health, wellness and the management of chronic health conditions. With SinfoniaRx’s STAR Improvement Programs, medication adherence modules can be custom selected to target desired goals. Expert clinical staff will work with the patient and their provider to understand the individual needs of the patient, increase medication adherence, and reach the STAR improvement goals of the plan.
* Existing systems even miss the one-drug-to-one-drug interactions that TRHC identifies.